Sale!

FGFR2 Gene Crouzon Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The FGFR2 Gene Crouzon Syndrome NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the FGFR2 gene responsible for Crouzon syndrome, a rare genetic disorder affecting skull and facial development. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide precise detection of genetic variations associated with craniosynostosis and facial dysmorphism. The test is essential for individuals showing symptoms of premature fusion of skull bones, protruding eyes, midface hypoplasia, or family history of craniofacial abnormalities. With results available in 3-4 weeks and requiring only a blood sample or extracted DNA, this test offers crucial diagnostic information for proper medical management and genetic counseling. The test is priced at $500 USD with a regular price of $700 USD, making advanced genetic testing accessible to families across the United States.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

FGFR2 Gene Crouzon Syndrome NGS Genetic DNA Test

Comprehensive Genetic Testing for Craniofacial Disorders

The FGFR2 Gene Crouzon Syndrome NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals and families affected by craniofacial abnormalities. This advanced genetic screening utilizes state-of-the-art Next-Generation Sequencing technology to identify specific mutations in the FGFR2 (Fibroblast Growth Factor Receptor 2) gene, which plays a critical role in bone development and cranial suture formation.

What Does This Test Measure?

This comprehensive genetic analysis specifically targets and sequences the entire FGFR2 gene to detect pathogenic variants associated with Crouzon syndrome. The test identifies:

  • Point mutations in the FGFR2 gene coding regions
  • Small insertions and deletions affecting protein function
  • Specific genetic variations linked to craniosynostosis
  • Mutations affecting tyrosine kinase domains critical for bone development
  • Genetic markers associated with variable expressivity and penetrance

Who Should Consider This Test?

This genetic test is recommended for individuals presenting with the following clinical indications:

  • Infants or children with premature fusion of cranial sutures (craniosynostosis)
  • Individuals with characteristic facial features including protruding eyes (proptosis)
  • Patients with underdeveloped midface (midface hypoplasia)
  • Those with beaked nose appearance and dental crowding
  • Individuals with family history of craniofacial syndromes
  • Parents planning pregnancy with known FGFR2 mutations in family
  • Patients undergoing evaluation for syndromic craniosynostosis

Clinical Benefits of Genetic Testing

Undergoing the FGFR2 Gene Crouzon Syndrome NGS Genetic DNA Test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out Crouzon syndrome with high precision
  • Early Intervention: Enables timely surgical planning and medical management
  • Genetic Counseling: Provides essential information for family planning decisions
  • Prognostic Information: Helps predict disease progression and potential complications
  • Personalized Care: Guides appropriate multidisciplinary treatment approaches
  • Peace of Mind: Reduces uncertainty and anxiety for affected families

Understanding Your Test Results

Your genetic test results will be thoroughly explained by our certified genetic counselors:

  • Positive Result: Indicates the presence of a pathogenic FGFR2 mutation confirming Crouzon syndrome diagnosis
  • Negative Result: Suggests absence of detectable FGFR2 mutations, though clinical evaluation remains important
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Determines inheritance patterns for family members

Test Specifications and Pricing

Test Parameter Details
Test Name FGFR2 Gene Crouzon Syndrome NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Pediatric Genetics

Pre-Test Requirements

Before scheduling your test, please ensure you have:

  • Complete clinical history of the patient
  • Scheduled genetic counseling session
  • Family pedigree chart documenting affected relatives
  • Relevant medical records and imaging studies

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and medical professionals ensures consistent, high-quality care regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about craniofacial conditions affect your family’s future. Our expert team of genetic specialists is ready to provide comprehensive testing, accurate diagnosis, and personalized guidance. Early genetic identification can significantly improve treatment outcomes and quality of life for individuals with Crouzon syndrome.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your FGFR2 Gene Crouzon Syndrome NGS Genetic DNA Test. Our compassionate team is available to answer your questions and guide you through every step of the testing process.